1-9 of 9
Jeroen J. W. M. Janssen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective validation of the prognostic relevance of CD34 + CD38 – AML stem cell frequency in the HOVON-SAKK132 trial

Clinical Trials & Observations
Lok Lam Ngai, Diana Hanekamp, Fleur Janssen, Jannemieke Carbaat-Ham, Maaike A. M. A. Hofland, Mona M. H. E Fayed, Angèle Kelder, Laura Oudshoorn-van Marsbergen, Willemijn J. Scholten, Alexander N. Snel, Costa Bachas, Jesse M. Tettero, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Arjan A. van de Loosdrecht, Johan A. Maertens, Markus G. Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Peter J. M. Valk, Patrycja Gradowska, Bob Löwenberg, David C. de Leeuw, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos
Journal: Blood
Blood (2023) 141 (21): 2657–2661.
https://doi.org/10.1182/blood.2022019160
Published: 2023
Includes: Supplemental data
Journal Articles

Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cells

Clinical Trials & Observations
Diana Hanekamp, Lok Lam Ngai, Jeroen J. W. M. Janssen, Arjan van de Loosdrecht, Gert J. Ossenkoppele, Jacqueline Cloos
Journal: Blood
Blood (2021) 137 (12): 1694–1697.
https://doi.org/10.1182/blood.2020007150
Published: 2021
Includes: Supplemental data
Journal Articles

Targeting miRNA-551b, a "Stemness"-like microRNA, to Eradicate AML (Stem) Cells

Tània Martiáñez, PhD, Noortje Van Gils, MSc, David Christian De Leeuw, MD PhD, Eline Vermue, Arjo Rutten, Fedor Denkers, Han J.M.P. Verhagen, MSc, Jeroen J. W. M. Janssen, MD PhD, Gert J. Ossenkoppele, MD PhD, Connie Jimenez, PhD, Linda Smit, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1494.
https://doi.org/10.1182/blood-2018-99-116024
Published: 2018
Journal Articles

Insulin-like Growth Factor Binding Protein 7 Activates the Retinoid Acid Differentiation Pathway in Acute Myeloid Leukemia Cells

Noortje Van Gils, MSc, Han J.M.P. Verhagen, MSc, Arjo Rutten, Renee X. Menezes, Mei-Ling Tsui, Esmee Dekens, Fedor Denkers, E Vermue, Jeroen J. W. M. Janssen, MD PhD, Gert J. Ossenkoppele, MD PhD, Linda Smit, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3937.
https://doi.org/10.1182/blood-2018-99-115858
Published: 2018
Journal Articles

RNA-based FLT3 -ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML

Brief Report
David G. J. Cucchi, Barbara Denys, Gertjan J. L. Kaspers, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Valérie de Haas, C. Michel Zwaan, Marry M. van den Heuvel-Eibrink, Jan Philippé, Tamás Csikós, Zinia Kwidama, Barbara de Moerloose, Eveline S. J. M. de Bont, Birgit I. Lissenberg-Witte, Sonja Zweegman, Femke Verwer, Karl Vandepoele, Gerrit Jan Schuurhuis, Edwin Sonneveld, Jacqueline Cloos
Journal: Blood
Blood (2018) 131 (22): 2485–2489.
https://doi.org/10.1182/blood-2017-12-819508
Published: 2018
Includes: Supplemental data
Journal Articles

"Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial

Susanne Saussele, MD, Johan Richter, MD PhD, Joelle Guilhot, PhD, Henrik Hjorth-Hansen, MD, Antonio Medina de Almeida, MD PhD, Jeroen J. W. M. Janssen, MD, Jiri Mayer, Prof, MD SCs, Perttu Koskenvesa, MD, Panayiotis Panayiotidis, MD PhD, Ulla Olsson-Strömberg, MD PhD, Juan Luis Steegmann, MD PhD, Hanne Vestergaard, MD, Hans Ehrencrona, MD PhD, Veli Kairisto, Kateřina Machová Poláková, PhD, Martin Müller, MD, Satu Mustjoki, MDPhD, Marc G. Berger, MD PhD, Philippe Rousselot, Martine Escoffre-Barbe, MD, Gabriel Etienne, MD PhD, Jolanta Dengler, MD, Françoise Rigal-Huguet, MD, Nikolas von Bubnoff, MD, Hana Klamova, MD, Edgar Faber, MD, François Guilhot, MD, Kourosh Lotfi, MD, Delphine Rea, MD, Tim H. Brümmendorf, MD, Gorgine de Greef, MD, Leif Stenke, MD, Franck Emmanuel Nicolini, MD PhD, Laurence Legros, MD PhD, Andreas Burchert, MD, Jaroslava Voglová, MD, Aude Charbonnier, MD, Emmanuel Gyan, MDPhD, Maria-Elisabeth Goebeler, MD, Peter E. Westerweel, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 313.
https://doi.org/10.1182/blood.V130.Suppl_1.313.313
Published: 2017
Journal Articles

Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib

Wendy Deenik, Bronno van der Holt, Jeroen J. W. M. Janssen, Isabel W. T. Chu, Peter J. M. Valk, Gert J. Ossenkoppele, Ilse P. van der Heiden, Pieter Sonneveld, Ron H. N. van Schaik, Jan J. Cornelissen
Journal: Blood
Blood (2010) 116 (26): 6144–6145.
https://doi.org/10.1182/blood-2010-07-296954
Published: 2010
Journal Articles

Restoration of the human stem cell niche after stem cell transplantation

Sonja Zweegman, Floortje L. Kessler, Johanna W. A. M. Celie, Jeroen J. W. M. Janssen, Jacob van den Born, Gerrit J. Schuurhuis, Angelika M. Dräger
Journal: Blood
Blood (2009) 114 (26): 5404–5406.
https://doi.org/10.1182/blood-2009-08-240176
Published: 2009
Journal Articles

Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia

Clinical Trials & Observations
Wendy Deenik, Bronno van der Holt, Gregor E. G. Verhoef, Willem M. Smit, Marie J. Kersten, Hanneke C. Kluin-Nelemans, Leo F. Verdonck, Augustin Ferrant, Anton V. M. B. Schattenberg, Jeroen J. W. M. Janssen, Pieter Sonneveld, Marinus van Marwijk Kooy, Shulamit Wittebol, Roelof Willemze, Pierre W. Wijermans, Petra H. M. Westveer, H. Berna Beverloo, Peter Valk, Bob Löwenberg, Gert J. Ossenkoppele, Jan J. Cornelissen
Journal: Blood
Blood (2008) 111 (5): 2581–2588.
https://doi.org/10.1182/blood-2007-08-107482
Published: 2008